Telmisartan to Valsartan Dose Equivalency
Telmisartan 80 mg once daily is approximately equivalent to valsartan 320 mg total daily (160 mg twice daily) based on ACC/AHA guideline target dosing for heart failure. 1
Guideline-Based Dose Equivalents
According to the 2020 ACC/AHA Heart Failure Performance Measures and 2022 AHA/ACC/HFSA Heart Failure Guidelines, the target doses for ARBs in heart failure with reduced ejection fraction are:
- Telmisartan: 80 mg once daily (total daily dose: 80 mg)
- Valsartan: 160 mg twice daily (total daily dose: 320 mg)
This represents a 4:1 ratio (valsartan:telmisartan) when comparing total daily target doses.
Context-Specific Considerations
For Heart Failure (HFrEF)
The dose equivalency is clearly established in guidelines:
- Telmisartan 80 mg daily = Valsartan 320 mg daily (160 mg BID)
- At 50% target: Telmisartan 40 mg = Valsartan 160 mg daily 1
For Hypertension
The 2017 ACC/AHA Hypertension Guidelines list dose ranges but don't specify direct equivalency:
The maximum doses (80 mg vs 320 mg) maintain the same 4:1 ratio.
Clinical Evidence Supporting Equivalency
Research data suggests telmisartan may actually be MORE potent than valsartan at these "equivalent" doses. Multiple head-to-head trials demonstrate:
- Telmisartan 80 mg provided superior 24-hour blood pressure control compared to valsartan 160 mg 5, 6
- When combined with hydrochlorothiazide 25 mg, telmisartan 80 mg reduced BP more than valsartan 160 mg 7, 8
- Telmisartan's longer half-life (24 hours vs 6-9 hours) provides more sustained BP reduction, particularly in the last 6 hours of dosing and after missed doses 5, 6
A 2024 network meta-analysis found olmesartan and telmisartan demonstrated superior efficacy-safety profiles compared to other ARBs including valsartan 9.
Practical Conversion Algorithm
When switching from valsartan to telmisartan:
- Valsartan 320 mg daily → Telmisartan 80 mg daily
- Valsartan 160 mg daily → Telmisartan 40 mg daily
- Valsartan 80 mg daily → Telmisartan 20 mg daily
When switching from telmisartan to valsartan:
- Telmisartan 80 mg daily → Valsartan 320 mg daily (160 mg BID)
- Telmisartan 40 mg daily → Valsartan 160 mg daily (80 mg BID or 160 mg once daily)
- Telmisartan 20 mg daily → Valsartan 80 mg daily
Important Caveats
- The 4:1 ratio is based on guideline target doses, not necessarily equipotent pharmacologic effects
- Clinical trials suggest telmisartan may provide superior BP control at these "equivalent" doses due to its longer half-life
- For cardiovascular risk reduction specifically, only telmisartan 80 mg has FDA approval; valsartan's evidence comes from heart failure trials at 320 mg daily 10
- Both drugs should be titrated to target doses shown effective in clinical trials for optimal morbidity and mortality reduction 1, 2